Pre-order Enquiry
Request Free Sample
Global Measles Vaccine Market Research Report 2021
SKU ID : QYR-19362325 | Publishing Date : 15-Oct-2021 | No. of pages : 119
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Measles Vaccine Market Research Report 2021
1 Measles Vaccine Market Overview1.1 Product Overview and Scope of Measles Vaccine
1.2 Measles Vaccine Segment by Type
1.2.1 Global Measles Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Measles Vaccine Segment by Application
1.3.1 Global Measles Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Children
1.3.3 Adults
1.4 Global Measles Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles Vaccine Revenue 2016-2027
1.4.2 Global Measles Vaccine Sales 2016-2027
1.4.3 Measles Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Measles Vaccine Market Competition by Manufacturers
2.1 Global Measles Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Measles Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Measles Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Measles Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Measles Vaccine Market Competitive Situation and Trends
2.5.1 Measles Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Measles Vaccine Players Market Share by Revenue
2.5.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles Vaccine Retrospective Market Scenario by Region
3.1 Global Measles Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Measles Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Measles Vaccine Market Facts & Figures by Country
3.3.1 North America Measles Vaccine Sales by Country
3.3.2 North America Measles Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Measles Vaccine Market Facts & Figures by Country
3.4.1 Europe Measles Vaccine Sales by Country
3.4.2 Europe Measles Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Measles Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Measles Vaccine Sales by Region
3.5.2 Asia Pacific Measles Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Measles Vaccine Market Facts & Figures by Country
3.6.1 Latin America Measles Vaccine Sales by Country
3.6.2 Latin America Measles Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Measles Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Measles Vaccine Sales by Country
3.7.2 Middle East and Africa Measles Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Measles Vaccine Historic Market Analysis by Type
4.1 Global Measles Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Measles Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Measles Vaccine Price by Type (2016-2021)
5 Global Measles Vaccine Historic Market Analysis by Application
5.1 Global Measles Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Measles Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Measles Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Measles Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi-Pasteur Measles Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Measles Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Measles Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Measles Vaccine Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Serum Institute of India Measles Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 China National Biotech Group
6.6.1 China National Biotech Group Corporation Information
6.6.2 China National Biotech Group Description and Business Overview
6.6.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 China National Biotech Group Measles Vaccine Product Portfolio
6.7.5 China National Biotech Group Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Corporation Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bavarian Nordic Measles Vaccine Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Emergent Biosolutions
6.9.1 Emergent Biosolutions Corporation Information
6.9.2 Emergent Biosolutions Description and Business Overview
6.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Emergent Biosolutions Measles Vaccine Product Portfolio
6.9.5 Emergent Biosolutions Recent Developments/Updates
6.10 Medimmune
6.10.1 Medimmune Corporation Information
6.10.2 Medimmune Description and Business Overview
6.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Medimmune Measles Vaccine Product Portfolio
6.10.5 Medimmune Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Measles Vaccine Description and Business Overview
6.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Johnson & Johnson Measles Vaccine Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 CSL Limited
6.12.1 CSL Limited Corporation Information
6.12.2 CSL Limited Measles Vaccine Description and Business Overview
6.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 CSL Limited Measles Vaccine Product Portfolio
6.12.5 CSL Limited Recent Developments/Updates
7 Measles Vaccine Manufacturing Cost Analysis
7.1 Measles Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Measles Vaccine
7.4 Measles Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Measles Vaccine Distributors List
8.3 Measles Vaccine Customers
9 Measles Vaccine Market Dynamics
9.1 Measles Vaccine Industry Trends
9.2 Measles Vaccine Growth Drivers
9.3 Measles Vaccine Market Challenges
9.4 Measles Vaccine Market Restraints
10 Global Market Forecast
10.1 Measles Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Measles Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Measles Vaccine by Type (2022-2027)
10.2 Measles Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Measles Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Measles Vaccine by Application (2022-2027)
10.3 Measles Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Measles Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Measles Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Measles Vaccine Market Research Report 2021
List of TablesTable 1. Global Measles Vaccine Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Measles Vaccine Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Measles Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Measles Vaccine Covered in This Study
Table 5. Global Measles Vaccine Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Measles Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Measles Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Measles Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Measles Vaccine Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Measles Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Measles Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Measles Vaccine Sales by Region (2016-2021) & (K MT)
Table 16. Global Measles Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Measles Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 19. North America Measles Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 23. Europe Measles Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Measles Vaccine Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Measles Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Measles Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Measles Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Measles Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Measles Vaccine Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Measles Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Measles Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Measles Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Measles Vaccine Sales (K MT) by Type (2016-2021)
Table 39. Global Measles Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Measles Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Measles Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Measles Vaccine Price (USD/MT) by Type (2016-2021)
Table 43. Global Measles Vaccine Sales (K MT) by Application (2016-2021)
Table 44. Global Measles Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Measles Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Measles Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Measles Vaccine Price (USD/MT) by Application (2016-2021)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. GSK Measles Vaccine Product
Table 52. GSK Recent Developments/Updates
Table 53. Sanofi-Pasteur Corporation Information
Table 54. Sanofi-Pasteur Description and Business Overview
Table 55. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Sanofi-Pasteur Measles Vaccine Product
Table 57. Sanofi-Pasteur Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Merck Measles Vaccine Product
Table 62. Merck Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Novartis Measles Vaccine Product
Table 67. Novartis Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Pfizer Measles Vaccine Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Serum Institute of India Corporation Information
Table 74. Serum Institute of India Description and Business Overview
Table 75. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Serum Institute of India Measles Vaccine Product
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. China National Biotech Group Corporation Information
Table 79. China National Biotech Group Description and Business Overview
Table 80. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. China National Biotech Group Measles Vaccine Product
Table 82. China National Biotech Group Recent Developments/Updates
Table 83. Bavarian Nordic Corporation Information
Table 84. Bavarian Nordic Description and Business Overview
Table 85. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Bavarian Nordic Measles Vaccine Product
Table 87. Bavarian Nordic Recent Developments/Updates
Table 88. Emergent Biosolutions Corporation Information
Table 89. Emergent Biosolutions Description and Business Overview
Table 90. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Emergent Biosolutions Measles Vaccine Product
Table 92. Emergent Biosolutions Recent Developments/Updates
Table 93. Medimmune Corporation Information
Table 94. Medimmune Description and Business Overview
Table 95. Medimmune Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Medimmune Measles Vaccine Product
Table 97. Medimmune Recent Developments/Updates
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Business Overview
Table 100. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Johnson & Johnson Measles Vaccine Product
Table 102. Johnson & Johnson Recent Developments/Updates
Table 103. CSL Limited Corporation Information
Table 104. CSL Limited Description and Business Overview
Table 105. CSL Limited Measles Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. CSL Limited Measles Vaccine Product
Table 107. CSL Limited Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Measles Vaccine Distributors List
Table 111. Measles Vaccine Customers List
Table 112. Measles Vaccine Market Trends
Table 113. Measles Vaccine Growth Drivers
Table 114. Measles Vaccine Market Challenges
Table 115. Measles Vaccine Market Restraints
Table 116. Global Measles Vaccine Sales Forecast by Type (2022-2027) & (K MT)
Table 117. Global Measles Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Measles Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Measles Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Measles Vaccine Sales Forecast by Application (2022-2027) & (K MT)
Table 121. Global Measles Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Measles Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Measles Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Measles Vaccine Sales Forecast by Region (2022-2027) & (K MT)
Table 125. Global Measles Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Measles Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Measles Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measles Vaccine
Figure 2. Global Measles Vaccine Market Share by Type in 2020 & 2027
Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
Figure 5. Global Measles Vaccine Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Adults
Figure 8. Global Measles Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Measles Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Measles Vaccine Sales 2016-2027 (K MT)
Figure 11. Global Measles Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Measles Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Measles Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Measles Vaccine Players: Market Share by Revenue in 2020
Figure 15. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Measles Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Measles Vaccine Sales Market Share by Region in 2020
Figure 18. Global Measles Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Measles Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Measles Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Measles Vaccine by Type (2016-2021)
Figure 45. Sales Market Share of Measles Vaccine by Application (2016-2021)
Figure 46. Sales Market Share of Measles Vaccine by Application in 2020
Figure 47. Revenue Share of Measles Vaccine by Application (2016-2021)
Figure 48. Revenue Share of Measles Vaccine by Application in 2020
Figure 49. Manufacturing Cost Structure of Measles Vaccine
Figure 50. Manufacturing Process Analysis of Measles Vaccine
Figure 51. Measles Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Keyplayers in Global Measles Vaccine Market Research Report 2021
GSKSanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
